278 related articles for article (PubMed ID: 16585022)
41. Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia.
Batorova A; Jankovicova D; Morongova A; Bubanska E; Prigancova T; Horakova J; Machyniakova M; Cervenka J; Chandoga J; Böhmer D; Mistrik M
Semin Thromb Hemost; 2016 Jul; 42(5):550-62. PubMed ID: 27235830
[TBL] [Abstract][Full Text] [Related]
42. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
43. Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).
Rocino A; Cortesi PA; Scalone L; Mantovani LG; Crea R; Gringeri A; ;
Haemophilia; 2016 Jan; 22(1):96-102. PubMed ID: 26278414
[TBL] [Abstract][Full Text] [Related]
44. Review of immune tolerance induction in hemophilia A.
Schep SJ; Schutgens REG; Fischer K; Boes ML
Blood Rev; 2018 Jul; 32(4):326-338. PubMed ID: 29482894
[TBL] [Abstract][Full Text] [Related]
45. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
Doshi BS; Rana J; Castaman G; Shaheen MA; Kaczmarek R; Butterfield JS; Meeks SL; Leissinger C; Biswas M; Arruda VR
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651716
[TBL] [Abstract][Full Text] [Related]
46. Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.
Jiménez-Yuste V; Oldenburg J; Rangarajan S; Peiró-Jordán R; Santagostino E
Haemophilia; 2016 Nov; 22(6):859-865. PubMed ID: 27329267
[TBL] [Abstract][Full Text] [Related]
47. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.
Oldenburg J; Austin SK; Kessler CM
Haemophilia; 2014 Sep; 20 Suppl 6():17-26. PubMed ID: 24975701
[TBL] [Abstract][Full Text] [Related]
48. Anti-A2 and anti-A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A.
Lapalud P; Rothschild C; Mathieu-Dupas E; Balicchi J; Gruel Y; Laune D; Molina F; Schved JF; Granier C; Lavigne-Lissalde G
J Thromb Haemost; 2015 Apr; 13(4):540-7. PubMed ID: 25603934
[TBL] [Abstract][Full Text] [Related]
49. Induction of immune tolerance in patients with hemophilia A and inhibitors.
Gruppo RA; Valdez LP; Stout RD
Am J Pediatr Hematol Oncol; 1992; 14(1):82-7. PubMed ID: 1550269
[TBL] [Abstract][Full Text] [Related]
50. Immunotolerance induction effectivity in hemophilia A children and neutralizing alloantibodies.
Soto A V; Cortez S D; González S M
Rev Chil Pediatr; 2020 Apr; 91(2):232-238. PubMed ID: 32730542
[TBL] [Abstract][Full Text] [Related]
51. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement.
Spena S; Garagiola I; Cannavò A; Mortarino M; Mannucci PM; Rosendaal FR; Peyvandi F;
J Thromb Haemost; 2018 Apr; 16(4):778-790. PubMed ID: 29399993
[TBL] [Abstract][Full Text] [Related]
52. French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
Rothschild C; Laurian Y; Satre EP; Borel Derlon A; Chambost H; Moreau P; Goudemand J; Parquet A; Peynet J; Vicariot M; Beurrier P; Claeyssens S; Durin A; Faradji A; Fressinaud E; Gaillard S; Guérin V; Guérois C; Pernod G; Pouzol P; Schved JF; Gazengel C
Thromb Haemost; 1998 Nov; 80(5):779-83. PubMed ID: 9843171
[TBL] [Abstract][Full Text] [Related]
53. Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry.
Zanon E; Pasca S; Pollio B; Santagostino E; Linari S; Tagliaferri A; Santoro C; Rocino A; Marino R; Aru B; Borchiellini A; Siragusa S; Coppola A
Haemophilia; 2019 Nov; 25(6):1003-1010. PubMed ID: 31603594
[TBL] [Abstract][Full Text] [Related]
54. Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.
Coppola A; Di Minno MN; Santagostino E
Br J Haematol; 2010 Sep; 150(5):515-28. PubMed ID: 20573153
[TBL] [Abstract][Full Text] [Related]
55. Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success.
Elalfy M; Elghamry I; Hassab H; Elalfy O; Andrawes N; El-Ekiaby M
Haemophilia; 2022 Jan; 28(1):65-72. PubMed ID: 34797008
[TBL] [Abstract][Full Text] [Related]
56. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
57. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
58. Inhibitors: A Need for Eradication?
Santagostino E; Young G; Escuriola Ettingshausen C; Jimenez-Yuste V; Carcao M
Acta Haematol; 2019; 141(3):151-155. PubMed ID: 30783066
[TBL] [Abstract][Full Text] [Related]
59. Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis.
Kenet G; Oladapo A; Epstein JD; Thompson C; Novack A; Nugent DJ
Haemophilia; 2017 Sep; 23(5):e394-e402. PubMed ID: 28641362
[TBL] [Abstract][Full Text] [Related]
60. ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study.
van den Berg HM; Mancuso ME; Königs C; D'Oiron R; Platokouki H; Mikkelsen TS; Motwani J; Nolan B; Santagostino E;
Thromb Haemost; 2020 Aug; 120(8):1166-1172. PubMed ID: 32572865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
